More importantly, the expression level of PSMA3-AS1 in PRAD was significantly higher in the GEPIA version 2 database (http://gepia2.cancer-pku.cn/#index, which is an upgraded version of GEPIA) [21]. This evidence concerns the gene PSMA3 and prostate adenocarcinoma.